Pharmacokinetic optimisation of oral hypoglycaemic therapy.

@article{Marchetti1991PharmacokineticOO,
  title={Pharmacokinetic optimisation of oral hypoglycaemic therapy.},
  author={Pablo A. Marchetti and Rosa Giannarelli and Anna Di Carlo and Renzo Navalesi},
  journal={Clinical pharmacokinetics},
  year={1991},
  volume={21 4},
  pages={308-17}
}
Two main classes of oral hypoglycaemic drugs, the sulphonylureas and the biguanides, are currently used in the therapy of type II, non-insulin-dependent diabetes mellitus (NIDDM). The basic pharmacokinetic properties of these agents are discussed with a view to efficient and safe treatment. Both first- and second-generation sulphonylureas are rapidly absorbed from the gastrointestinal tract. In the plasma compartment, these drugs are strongly bound to serum proteins. All sulphonylureas are… CONTINUE READING

Similar Papers

Loading similar papers…